The following statement can be attributed to Ari Hoffnung, Chief Executive Officer of Vireo Health of New York, one of only 10 organizations licensed in the state to grow, cultivate, manufacture and sell medical cannabis: "I agree with the conclusions drawn in the state Department of Health's marijuana legalization impact assessment. Legalization will not only help reduce opioid deaths and discrimination against people of color but also bring substantial tax revenue to the state. It’s time to end the war...
Read more
STATEMENT: Vireo Health of New York CEO Ari Hoffnung responds to Health Department marijuana impact assessment
Statement from Vireo Health on Department of Health’s Decision to Improve Patient Access to Medical Marijuana for New Yorkers Prescribed Opioids
The following statement regarding New York State’s plan to allow medical cannabis to be used as an alternative to prescription opioids can be attributed to Dr. Stephen Dahmer, Chief Medical...
Read more
Statements from Vireo Health on the Eve of New York State Reaching the 50,000 Medical Marijuana Patient Milestone
“Since serving our very first patient in New York on January 7 of 2016, we have had the unprecedented opportunity to support thousands with serious conditions that include chronic pain,...
Read more
STATEMENT FROM VIREO HEALTH OF NEW YORK CHIEF MEDICAL OFFICER ON FEDERAL ANNOUNCEMENT ON MEDICAL CANNABIS RESEARCH
Statement from Stephen Dahmer, M.D. Chief Medical Officer of Vireo Health of New York Re: Federal announcement reducing barriers for medical cannabis research August 11, 2016 “We view today’s decision...
Read more
STATEMENT FROM VIREO HEALTH OF NEW YORK CHIEF MEDICAL OFFICER ON FEDERAL ANNOUNCEMENT ON MEDICAL CANNABIS RESEARCH
Statement from Stephen Dahmer, M.D. Chief Medical Officer of Vireo Health of New York Re: Federal announcement reducing barriers for medical cannabis research August 11, 2016 “We view today’s decision...
Read more